4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-22-051912
Director bought 88,797 shares at an average $1.24 ($110,500)
From the SEC's structured data for this filing
Trades in this filing
HILZINGER KURT J · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-29 | Purchase : show line 1 in the form | +13,800 | $1.19 | $16,422 | 286,917 | D |
| 2022-09-30 | Purchase : show line 2 in the form | +33,199 | $1.26 | $41,831 | 320,116 | D |
| 2022-10-03 | Purchase : show line 3 in the form | +41,798 | $1.25 | $52,248 | 361,914 | D |
| Open-market purchases · 88,797 sh · avg $1.24 · $110,500 | ||||||
Loading xslF345X03/doc4.xml…